Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_assertion type Assertion NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_head.
- NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_provenance.
- NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_assertion evidence source_evidence_literature NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_provenance.
- NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_assertion SIO_000772 22886548 NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_provenance.
- NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_assertion wasDerivedFrom befree-2016 NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_provenance.
- NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_assertion wasGeneratedBy ECO_0000203 NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_provenance.